Citation Impact
Citing Papers
DNA Damage–Specific Control of Cell Death by Cryptochrome in p53-Mutant Ras–Transformed Cells
2012 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression
2011
Hallmarks of Cancer: The Next Generation
2011 Standout
Inference and analysis of cell-cell communication using CellChat
2021 Standout
Mutation analysis of P73 and TP53 in Merkel cell carcinoma
2000
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
2016 Standout
Chemosensitivity linked to p73 function
2003 StandoutNobel
Nucleotide Binding by the MDM2 RING Domain Facilitates Arf-Independent MDM2 Nucleolar Localization
2003 StandoutNobel
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
2005 StandoutNobel
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
2000 StandoutNobel
p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent
1999
Role for the p53 homologue p73 in E2F-1-induced apoptosis
2000 StandoutNatureNobel
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Intrinsically unstructured proteins and their functions
2005 Standout
Expression of p73 and Its Relation to Histopathology and Prognosis in Hepatocellular Carcinoma
1999
Mutational analysis of thep73Gene in human breast cancers
1999
Infrequent somatic mutations of thep73genein various human cancers
1999
Lack ofp73 mutations and late occurrence ofp73 allelic deletions in melanoma tissues and cell lines
1999
p53 family genes: structural comparison, expression and mutation
1999
Choosing anticancer drug targets in the postgenomic era
1999 StandoutNobel
The Human p73 Promoter: Characterization and Identification of Functional E2F Binding Sites
2002 StandoutNobel
Psoriasis
2021 Standout
The p53 pathway
1999
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs
2004
Cancer genes and the pathways they control
2004 Standout
Transactivation-deficient ΔTA-p73 Inhibits p53 by Direct Competition for DNA Binding
2002
The use of combinations of monoclonal antibodies in clinical oncology
2015
Oncogenes Induce and Activate Endogenous p73 Protein
2001
Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data
2014
Targeting apoptosis in cancer therapy
2020 Standout
The role of IL-1 in the pathogenesis of heart disease
2009
The expression of p73 is increased in lung cancer, independent of p53 gene alteration
1999
Overexpression of the wild type p73 gene in human bladder cancer
1999
p73 gene transcripts in human brain tumors: overexpression and altered splicing in ependymomas
1999
Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73
2000
The IL-1 family: regulators of immunity
2010
The p53 gene family
1999 StandoutNobel
Polymorphisms in the Sclerosteosis/van Buchem Disease Gene (SOST) Region Are Associated with Bone-Mineral Density in Elderly Whites
2004 StandoutNobel
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Molecular Cloning and Functional Characterization of the Upstream Promoter Region of the Human p73 Gene
1999
Agonists and Antagonists of TGF-β Family Ligands
2016
Chiral separation by enantioselective liquid–liquid extraction
2010 StandoutNobel
p73 mutations are not detected in sporadic and hereditary breast cancer
1999
p63 and p73: old members of a new family
2000 StandoutNobel
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
2009 StandoutNature
The large T antigen of simian virus 40 binds and inactivates p53 but not p73.
1998
Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
1999
Mutation and expression analysis of thep73 gene in prostate cancer
1999
Clinical targeting of the TNF and TNFR superfamilies
2013
Structural analysis of cytokines comprising the IL-10 family
2010
Role of the newer p53 family proteins in malignancy
2001 StandoutNobel
Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype
1999
The Emerging p53 Gene Family
1999 StandoutNobel
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
2000 StandoutNatureNobel
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
2012
Inactivation of the p53-homologue p73 by the mdm2-oncoprotein
1999
Allelic expression of the putative tumor suppressor gene p73 in human fetal tissues and tumor specimens
2000
Promoter specificity and stability control of the p53-related protein p73
1999
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
2001 Standout
Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53
2000
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Head and Neck Cancer
2001 Standout
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
2005 Standout
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
p73: Friend or foe in tumorigenesis
2002
Enantioseparation of mandelic acid enantiomers in ionic liquid aqueous two-phase extraction systems
2013
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
Ionic-Liquid-Mediated Extraction and Separation Processes for Bioactive Compounds: Past, Present, and Future Trends
2017 Standout
P73 gene expression in ovarian cancer tissues and cell lines.
2000
Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
1999
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Mouse p73 gene maps to the distal part of chromosome 4 and might be involved in the progression of gamma-radiation-induced T-cell lymphomas.
1999
Accumulation of the FACT complex, as well as histone H3.3, serves as a target marker for somatic hypermutation
2013 StandoutNobel
Structure and Nanostructure in Ionic Liquids
2015 Standout
Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines.
1998
Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening
2014
Ionic liquids and ultrasound in combination: synergies and challenges
2014
Mutational and expression analysis of the p73 gene in melanoma cell lines.
1999
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
MDM2 Suppresses p73 Function without Promoting p73 Degradation
1999 StandoutNobel
Oligosaccharyltransferase: A Gatekeeper of Health and Tumor Progression
2019
Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation.
1999
The Roles of Therapy-Induced Autophagy and Necrosis in Cancer Treatment
2007
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Combination therapy in combating cancer
2017 Standout
Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis.
1999
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Surfing the p53 network
2000 StandoutNature
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Failure of viral oncoproteins to target the p53-homologue p51A
1999
p53 family update: p73 and p63 develop their own identities.
2001 StandoutNobel
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
AIS is an oncogene amplified in squamous cell carcinoma
2000
Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
1999
Combining TRAIL with PI3 Kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling
2013
Frequent alteration of p63 expression in human primary bladder carcinomas.
2000
Physiology of Microglia
2011 Standout
Chemical Glycoproteomics
2016 StandoutNobel
Works of Yang Pan being referenced
Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours
2011
Cbfa1/RUNX2 Directs Specific Expression of the Sclerosteosis Gene (SOST)
2004
A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
2013
Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types
2010
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
2013
Loss and gain of N-linked glycosylation sequons due to single-nucleotide variation in cancer
2018
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer
2013
Enantioselective Partitioning of Racemic Ibuprofen in a Biphasic Recognition Chiral Extraction System
2010
Enantioselective separation of R,S-phenylsuccinic acid by biphasic recognition chiral extraction
2009
Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer
2011
Activation of p73 silent allele in lung cancer.
1998
Combination use of ultrasound irradiation and ionic liquid in enzymatic isomerization of glucose to fructose
2012
A framework for organizing cancer-related variations from existing databases, publications and NGS data using a High-performance Integrated Virtual Environment (HIVE)
2014
Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy
2007
Follistatin-Related Protein and Follistatin Differentially Neutralize Endogenous vs. Exogenous Activin
2002
Separation of flurbiprofen enantiomers by biphasic recognition chiral extraction
2010
A new nomenclature for IL-1-family genes
2001